The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling
about
Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signalingActivation of interferon regulatory factor 5 by site specific phosphorylationA TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signalingInnate immune recognition of viral infectionPathogen recognition and inflammatory signaling in innate immune defensesBinding specificity of Toll-like receptor cytoplasmic domainsRole of type I interferons in the activation of autoreactive B cellsThe TLR and IL-1 signalling network at a glanceA Novel Unsupervised Method to Identify Genes Important in the Anti-viral Response: Application to Interferon/Ribavirin in Hepatitis C PatientsInduction of IFN-β and the Innate Antiviral Response in Myeloid Cells Occurs through an IPS-1-Dependent Signal That Does Not Require IRF-3 and IRF-7Intrinsic Cellular Defenses against Virus Infection by Antiviral Type I InterferonInsights into interferon regulatory factor activation from the crystal structure of dimeric IRF5IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitinationTLR signalingInteraction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironmentAn innate immunity signaling process suppresses macrophage ABCA1 expression through IRAK-1-mediated downregulation of retinoic acid receptor alpha and NFATc2Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-betaTranscriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonistsCharacterization of the interferon-producing cell in mice infected with Listeria monocytogenesFunctional analysis of a dominant negative mutation of interferon regulatory factor 5NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis.Infection in systemic lupus erythematosus: friend or foe?Interleukin-1 Receptor-Associated Kinase-1 (IRAK-1) functionally associates with PKCepsilon and VASP in the regulation of macrophage migrationStructural insights into interferon regulatory factor activation.Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosusTLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta primingDifferential gene expression downstream of Toll-like receptors (TLRs): role of c-Src and activating transcription factor 3 (ATF3).Interferon regulatory factor 6 differentially regulates Toll-like receptor 2-dependent chemokine gene expression in epithelial cells.Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88.Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections.Interferon alpha in systemic lupus erythematosusInterferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.The TIR-domain containing adaptor TRAM is required for TLR7 mediated RANTES production.Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunityInterferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection.Genetic associations in type I interferon related pathways with autoimmunityToll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma
P2860
Q24300680-4755F72A-B9C2-467C-A127-12914A2F6B19Q24307504-B7722E85-BDCA-46FC-949D-CC3AF54FDF7BQ24337616-1EFD76D1-448A-48F5-83AB-367E97055DBDQ24498364-34FE9B02-7472-4F8C-9D90-AAF525C91733Q24643034-C0A14741-BB61-41D1-B992-4543B8BD10A8Q24652591-6AE982E2-B97C-4433-926F-8C69A6178C5EQ26858821-386C09C2-4044-4EA6-9FEC-DE954A78CC97Q27013358-BA1FD729-394D-4FA9-9F9F-A300B8E0DFC5Q27481065-5977B232-DDF5-4A4A-B61A-216EDA96FE64Q27489661-2BC9C3AB-923B-4155-AE45-BB73A29F7381Q27490770-813BC8F1-152C-439A-B279-7BA6BB41C17DQ27652424-F0C90F51-27CC-4781-85C5-2FA3F892F882Q28249343-8DFF8C6A-A758-4281-8E34-B05522711294Q28291637-55640B61-E813-46E7-9D7F-B7ABDCC95D81Q28389479-C0A554D3-3720-4368-B12F-A5F4C0C8490EQ28504786-2C909046-3B2B-47EC-A56D-117406E3C956Q30498311-75A448ED-5729-440E-A3F2-BDF97FBCF441Q33302568-0F1E544D-2EC7-4E2B-AB0B-21DF478A1C9BQ33422966-EAA1C316-32C0-4AED-9882-AAF0020208BEQ33442833-8CAE2267-729C-49B7-BDD1-2DE797034FF7Q33478396-07102B7E-4333-406C-A82D-934C87AD7589Q33696879-AB87F61A-DA4C-42BB-89EA-51C445B310CAQ33706807-82D30765-02F3-4DD2-91E1-B209DF60C2DAQ33756083-33376426-2F3A-4043-9DDF-701F3E8E070FQ33799144-100E3B36-D74C-4301-8DCF-0CF94E77D997Q33804141-DA2C5986-4FC1-450D-A6C3-DB7656371712Q33807599-D087098C-D953-4997-8D18-30C8066F5A86Q33883292-368E86FB-FBDD-4F45-8A9C-A03D4B00FC88Q33888640-67125D55-B4A4-41B2-9D47-5CB5012F8D57Q33911908-2048BEF3-85B3-414A-902A-38809DABB44EQ33911955-51493AED-C046-45A4-9015-D67FDA5AE7F7Q33961179-18D227D5-7032-4FE3-826D-12E734197F99Q33975488-CE8F073B-9CE6-4279-B35A-75BC0495ED1CQ33987481-84F41A00-2977-4FF9-BFA1-9E34D0F2BBECQ34166417-0E95509D-E94A-4C02-BE85-28AC0B84F328Q34187236-23449F94-DEC3-4A94-8ABC-CAA2EFEC9879Q34261880-9B706946-5263-4900-AB01-AEF33166267DQ34350182-759A30E0-99FF-47C8-B0C0-7EC12903F3A9Q34405076-8322F4A2-B494-417D-80AA-69BD8D257AE7Q34408939-F3FAF3C5-5D61-4E60-9A62-EC13F217E3F4
P2860
The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The interferon regulatory fact ...... toll-like receptor 7 signaling
@ast
The interferon regulatory fact ...... toll-like receptor 7 signaling
@en
The interferon regulatory fact ...... toll-like receptor 7 signaling
@nl
type
label
The interferon regulatory fact ...... toll-like receptor 7 signaling
@ast
The interferon regulatory fact ...... toll-like receptor 7 signaling
@en
The interferon regulatory fact ...... toll-like receptor 7 signaling
@nl
prefLabel
The interferon regulatory fact ...... toll-like receptor 7 signaling
@ast
The interferon regulatory fact ...... toll-like receptor 7 signaling
@en
The interferon regulatory fact ...... toll-like receptor 7 signaling
@nl
P2093
P3181
P356
P1476
The interferon regulatory fact ...... toll-like receptor 7 signaling
@en
P2093
Annett Schoenemeyer
Betsy J Barnes
Douglas T Golenbock
Eicke Latz
Katherine A Fitzgerald
Margo E Mancl
Nadege Goutagny
Paula M Pitha
P304
P3181
P356
10.1074/JBC.M412584200
P407
P577
2005-04-29T00:00:00Z